White Paper

Multimillion cash investment injected into the global nanodrug market

November 5, 2015

Based on an €18.5-million investment, with an additional €3.0 million expected later in 2015, under the lead of TVM Capital Life Sciences, a global VC company in life sciences, leon-nanodrugs is starting its international expansion, particularly into the US and China, with a focus on the co-development of nanotechnology based reformulations of brands and generics. CSO and co-founder Dr Wolfgang Beier answers World Pharmaceutical Frontiers’ questions.

Download to find out more.